Regulated Markets

Fourrts has become a respected player of contract manufacturing of customer’s products across UK/EU/Australia/Canada countries. While it has UKMHRA and EU GMP approval from both Malta and Germany, Customer based Desk Top Approval is available for Australia and Canada.

Holding UK Market Authorization for Metformin F/c Tabs 500/850mgI; buprofen F/c Tabs 200/400/600mg; Paracetamol Tabs/Caps 500mg; Propranolol Tabs 10/40mg; Atenolol Tabs 25/50/100mg; Furosemide Tabs 20/40mg.

Fourrts has initiated manufacture of exhibit batches towards dossier filing with FDA authorities and the Plant approval is expected by Mar 2023.

World Class manufacturing facility for Tabs and Caps housed with state of art Production and Analytical Lab Equipments apart from R & D Lab – a miniature production facility. R & D Lab is supported by a dedicated team of scientists who are committed to do both site transfer and tech transfer products besides product development.

Seeking strategic alliances to extend the facility for Contract Manufacturing Operations to countries like Hungary, Romania, Czech Republic, Portugal, Netherlands, Italy, France, Spain, Germany, Poland, Greece, Australia, Canada and other regulated markets.

Wish to develop generic pharmaceutical formulations and collaborate with business partners for products going off-patent.

Reach Out for business requirements:

Mr. K.S. VASU
Chief Executive – Finance & Business Development

Email: vasu.ks@fourrts.com

Phone: +91 98401 38611